Cargando…
Melanoma: tumor microenvironment and new treatments
In the recent past years, many discoveries in the tumor microenvironment have led to changes in the management of melanoma and it is rising up hopes, specially, to those in advanced stages. FDA approved seven new drugs from 2011 to 2014. They are: Vemurafenib, Dabrafenib and Trametinib, kinases inhi...
Autores principales: | Giavina-Bianchi, Mara Huffenbaecher, Giavina-Bianchi Junior, Pedro Francisco, Festa Neto, Cyro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429098/ https://www.ncbi.nlm.nih.gov/pubmed/28538872 http://dx.doi.org/10.1590/abd1806-4841.20176183 |
Ejemplares similares
-
Worse survival of invasive melanoma patients in men and “de novo” lesions()()
por: Giavina-Bianchi, Mara Huffenbaecher, et al.
Publicado: (2020) -
Inflammasomes and dermatology
por: de Sá, Daniel Coelho, et al.
Publicado: (2016) -
Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
por: Giavina-Bianchi, Mara Huffenbaecher, et al.
Publicado: (2019) -
Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous Melanoma
por: Giavina-Bianchi, Mara, et al.
Publicado: (2015) -
Management of Malignant Melanoma
por: Mun, Goo-Hyun
Publicado: (2012)